The current coronavirus disease 2019 (COVID-19) pandemic has had devastating impact on
populations around the world. The high mortality rates in patients with COVID-19 has been …

New-onset atrial fibrillation (NOAF) is the most frequently encountered cardiac arrhythmia
observed in patients with COVID-19 infection, particularly in Intensive Care Unit (ICU) …

Background During the COVID-19 pandemic, guideline documents on the management of
anticoagulation were rapidly published. However, these documents did not follow a …

Objective To describe the clinical profile, risk of complications and impact of anticoagulation
in COVID-19 hospitalized patients, according to the presence of atrial fibrillation (AF) …

Infection contributes to developing cardiac arrhythmias, such as atrial fibrillation (AF), which
causes over 25% of ischaemic stroke. We analysed a hospital coding database of patients …

Study design We performed a retrospective study, including the patients with SARS-CoV-2
pneumonia who were admitted to our hospital between March 2020 and August 2021. We …

The Coronavirus 2019 (COVID-19) pandemic, caused by the Severe Acute Respiratory
Syndrome Coronavirus-2 (SARS-CoV-2) virus, has resulted in unprecedented morbidity and …

Background Pre-existing and new-onset atrial fibrillation (NOAF) is a common arrhythmia in
COVID-19 patients and is related to increased mortality. CHA2DS2-VASc score was initially …

Objective To assess the impact of new-onset atrial fibrillation (AF) on patients hospitalized
with coronavirus disease 2019 (COVID-19). Methods Multicenter and retrospective study …

Background: The new coronavirus disease (COVID-19), a pandemic infection caused by
severe acute respiratory syndrome coronavirus (SARS-CoV-2), had a deep global influence …